DE69729730D1 - Transgene mäuse, die den leukämie inhibierungsfaktor exprimieren können - Google Patents

Transgene mäuse, die den leukämie inhibierungsfaktor exprimieren können

Info

Publication number
DE69729730D1
DE69729730D1 DE69729730T DE69729730T DE69729730D1 DE 69729730 D1 DE69729730 D1 DE 69729730D1 DE 69729730 T DE69729730 T DE 69729730T DE 69729730 T DE69729730 T DE 69729730T DE 69729730 D1 DE69729730 D1 DE 69729730D1
Authority
DE
Germany
Prior art keywords
transgenic mice
pituitary
express
inhibition factor
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69729730T
Other languages
English (en)
Other versions
DE69729730T2 (de
Inventor
Shlomo Melmed
Sadanori Akita
Carol Readhead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cedars Sinai Medical Center
Original Assignee
Cedars Sinai Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cedars Sinai Medical Center filed Critical Cedars Sinai Medical Center
Publication of DE69729730D1 publication Critical patent/DE69729730D1/de
Application granted granted Critical
Publication of DE69729730T2 publication Critical patent/DE69729730T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
DE69729730T 1996-05-09 1997-04-29 Transgene mäuse, die den leukämie inhibierungsfaktor exprimieren können Expired - Fee Related DE69729730T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US647401 1996-05-09
US08/647,401 US5824838A (en) 1996-05-09 1996-05-09 Transgenic mouse model for pituitary disorders associated with LIF overexpression and/or GH underexpression, and its use for testing therapeutic drugs for the conditions
PCT/US1997/007177 WO1997042312A1 (en) 1996-05-09 1997-04-29 Transgenic mammals capable of expressing leukemia inhibitory factor

Publications (2)

Publication Number Publication Date
DE69729730D1 true DE69729730D1 (de) 2004-08-05
DE69729730T2 DE69729730T2 (de) 2005-07-07

Family

ID=24596845

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69729730T Expired - Fee Related DE69729730T2 (de) 1996-05-09 1997-04-29 Transgene mäuse, die den leukämie inhibierungsfaktor exprimieren können

Country Status (9)

Country Link
US (1) US5824838A (de)
EP (1) EP0914419B1 (de)
JP (1) JP2000509606A (de)
AT (1) ATE270328T1 (de)
DE (1) DE69729730T2 (de)
DK (1) DK0914419T3 (de)
ES (1) ES2219764T3 (de)
PT (1) PT914419E (de)
WO (1) WO1997042312A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP053197A0 (en) * 1997-11-26 1997-12-18 Amrad Operations Pty. Limited Compositions
AU744333B2 (en) * 1997-11-26 2002-02-21 Amrad Operations Pty. Limited Compositions of leukaemia inhibitory factor
CA2333307A1 (en) 1998-07-06 2000-01-13 The Government Of The United States Of America As Represented By The Sec Retary, Department Of Health And Human Services Compositions and methods for in vitro fertilization
US6541244B1 (en) 1999-06-07 2003-04-01 Cedars-Sinai Medical Center Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans
MXPA02004666A (es) 1999-11-12 2003-06-24 Fibrogen Inc Gelatinas recombinantes.
EP3224380A1 (de) 2014-11-25 2017-10-04 The Broad Institute Inc. Klonale hämatopoese
US11168369B2 (en) 2014-11-25 2021-11-09 The Brigham And Women's Hospital, Inc. Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
ES2842501T5 (es) 2015-09-21 2023-04-13 Modern Meadow Inc Materiales compuestos de tejido reforzados con fibras
ES2807727T3 (es) 2016-02-15 2021-02-24 Modern Meadow Inc Material compuesto biofabricado
CA3008850A1 (en) 2017-06-29 2018-12-29 Modern Meadow, Inc. Yeast strains and methods for producing collagen
AU2018253595A1 (en) 2017-11-13 2019-05-30 Modern Meadow, Inc. Biofabricated leather articles having zonal properties
US11352497B2 (en) 2019-01-17 2022-06-07 Modern Meadow, Inc. Layered collagen materials and methods of making the same
EP3983551A4 (de) * 2019-06-14 2023-10-18 The Regents Of The University Of California Dna-konstrukt zum targeting therapeutischer moleküle gegen krankes gewebe durch immunzellen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4736866A (en) * 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
ATE132266T1 (de) * 1987-05-01 1996-01-15 Stratagene Inc Mutagenesetest durch verwendung von nicht menschlichen lebewesen, die test-dns-sequenzen enthalten
US5175385A (en) * 1987-09-03 1992-12-29 Ohio University/Edison Animal Biotechnolgy Center Virus-resistant transgenic mice
US5175384A (en) * 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5215904A (en) * 1989-01-27 1993-06-01 Wisconsin Alumni Research Foundation Method for producing a recombinant mammal in vivo
US5175383A (en) * 1989-02-17 1992-12-29 President And Fellows Of Harvard College Animal model for benign prostatic disease
US5223610A (en) * 1990-05-18 1993-06-29 The Scripps Research Institute Cholera toxin gene regulated by growth hormone promoter

Also Published As

Publication number Publication date
DK0914419T3 (da) 2004-09-06
JP2000509606A (ja) 2000-08-02
US5824838A (en) 1998-10-20
ATE270328T1 (de) 2004-07-15
EP0914419B1 (de) 2004-06-30
PT914419E (pt) 2004-10-29
DE69729730T2 (de) 2005-07-07
WO1997042312A1 (en) 1997-11-13
ES2219764T3 (es) 2004-12-01
EP0914419A1 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
ATE270328T1 (de) Transgene mäuse, die den leukämie inhibierungsfaktor exprimieren können
ES2187505T3 (es) Elementos cis de proteinas de cuerpo oleoso como señales reguladoras.
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
DE60129799D1 (de) Verfahren zur steigerung des haarwuchses durch wnt polypeptid
ATE57690T1 (de) Pyrazolin mit insektizidischer aktivitaet.
ATE202785T1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE60133271D1 (de) Behandlung von knorpelerkrankungen
ATE190352T1 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
ATE540108T1 (de) Familie gh 61 polypeptiden
MXPA02009313A (es) Acilsulfimidas heterociclicas, un metodo para su produccion, agentes que contienen las mismas y su uso como plaguicidas.
DK0556171T3 (da) Væksthormon-antagonister
BG105603A (en) Control of arthropods in animals
ATE312919T1 (de) Schmerz signalisierende moleküle
DE59303729D1 (de) Tierfutter zur leistungssteigerung
ATE406438T1 (de) Menschliches homolog aus der familie der metalloproteasen
MXPA02004484A (es) Metodos para determinar el sexo de mamiferos que no son seres humanos.
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
ATE324906T1 (de) Verwendung von chimäres il6-il6r in huntingtonskrankheit
ATE381324T1 (de) Verwendung von mecamylamine zur behandlung von neuropsychiatrischen krankheiten die auf nicotin ansprechen
PT975630E (pt) Sulfoniloxadiazolonas e sua utilizacao como microbicidas
DE69203723D1 (de) Verfahren zur Erhöhung der Zucht von Vieh.
ATE472603T1 (de) Atrsp gen promotoren
UA33231A (uk) Спосіб добору великої рогатої худоби з прогнозованим ефектом селекції по молочності і м'ясності
UA28426A (uk) Спосіб заводського розведення кефалі піленгасу

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee